Actually ADHD | Medication Strategies & Clinical Wisdom cover art

Actually ADHD | Medication Strategies & Clinical Wisdom

Actually ADHD | Medication Strategies & Clinical Wisdom

By: Jonathan Murphy PMHNP-BC
Listen for free

Adult ADHD from the board-certified PMHNP behind the YouTube channel Focus Path and the book The Process. Clinical perspective on medication, frameworks, and the conversations the internet hasn't been having.© 2026 Focus Path Systems Hygiene & Healthy Living Physical Illness & Disease Psychology Psychology & Mental Health
Episodes
  • Seven Reasons ADHD Medication Fails You
    Jun 20 2026

    Seven reasons your ADHD medication isn't working. Jonathan Murphy, PMHNP-BC, walks through the clinical patterns that show up when adult ADHD medication fails to deliver the expected response — and what each pattern actually points toward.

    This episode covers:

    • Why daily consistency matters more than the cultural narrative around "as needed" stimulant use
    • Why ADHD is a disorder of inconsistency and how consistent medication produces a different person over time
    • The diagnostic question hiding underneath medication non-response: do you actually have ADHD
    • The OCPD distinction — patients who don't fluctuate in attention but instead narrow their perception of what's possible
    • Why patients with primary ADHD plus secondary anxiety often confuse the two and reach for the wrong primary treatment
    • The honeymoon period of stimulant response and why a sudden three-day drop signals underlying depression
    • Why immediate-release tablets can't deliver consistent symptom control and what the spike-and-crash actually represents pharmacokinetically
    • The undertreatment pattern: 5-10 milligram Adderall starting doses from prescribers uncomfortable with adult ADHD medication
    • The 50/50 split between adults who respond best to methylphenidate versus amphetamine
    • Why hunting down a specific generic manufacturer creates more problems than it solves
    • The Reddit r/ADHD ideology breakdown: how tribal identity formation distorts clinical reasoning around ADHD treatment
    • The three components of online ADHD tribal narrative: the idea (our brains are different), the sentiment (it's not fair nobody noticed), the custom (complaint without accountability)
    • Why the podcast operates with less filter than the YouTube channel and what that medium difference enables

    This is the fifth episode of Actually ADHD. Earlier episodes covered the optimization blueprint, the medication walkthrough, and the Goldilocks Zone framework. The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

    Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

    For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

    Show More Show Less
    12 mins
  • How to Know You're On The Correct Dosage | ADHD Medication Goldilocks Guide
    Jun 20 2026

    How to know you're on the correct dose of ADHD medication. Jonathan Murphy, PMHNP-BC, breaks down the Goldilocks Zone — the framework for identifying the right dose of stimulant medication for an adult with ADHD. Not too little, not too much, just right.

    This episode covers:

    • Why there is no universal "right dose" or "best medication" for ADHD
    • The Goldilocks Zone: too low means tired, too high means tweaking out, just right means calm and functional
    • Duration as part of the optimization equation and what a crash actually signals
    • Why side effects and poor toleration are not necessary parts of ADHD treatment
    • The pattern of overstimulation on amphetamines pointing toward methylphenidate
    • The pattern of zombification on methylphenidate pointing toward non-stimulants or dexmethylphenidate
    • Why extended-release technology is what makes optimization possible at all
    • Tonic versus phasic dopamine receptor activation and why consistency is the goal
    • The myth of toleration and the normal three-to-four-week adjustment from initial response to maintenance dose
    • Why the diagnostic criteria of ADHD are validated by medication response, not just by symptom checklist
    • The "prescriber as cop" framing: how the Controlled Substance Act has distorted clinical decision-making
    • Why a patient who feels shame at the pharmacy can't ask the simple question "how do I know if I'm on the right dose?"
    • The role of secondary symptom resolution — forgetfulness and organizational difficulty as downstream effects of consistent medication
    • Why one month is the minimum trial period and what shooting at moving targets looks like
    • The internet-filtered version of ADHD: how tribal identity formation distorts clinical reasoning
    • Why guanfacine monotherapy in adults is sometimes a signal to reconsider the diagnosis, not to celebrate the medication

    This is the fourth episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

    Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

    For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

    Show More Show Less
    11 mins
  • Adderall XR v. Ritalin (Amphetamine v. Methylphenidate)
    Jun 18 2026

    A deep dive into the extended-release ADHD stimulant medications. Jonathan Murphy, PMHNP-BC, walks through every major option in the methylphenidate and amphetamine categories, the clinical reasoning behind choosing one over another, and the specific patient presentations that point toward each medication.

    This episode covers:

    • The two stimulant categories: methylphenidate and amphetamine
    • OROS technology in Concerta versus micro-bead technology in newer extended-release formulations
    • Why Concerta's absorption can be spotty and when to move to Ritalin LA
    • The methylphenidate bead ratios: 50/50, 60/40, 70/30 and what each one does clinically
    • Aptensio, Metadate, and Jornay PM as alternatives within the methylphenidate family
    • Focalin (dexmethylphenidate) as the second-line methylphenidate when standard formulations don't deliver
    • The amphetamine side: Adderall XR, Vyvanse, Dexedrine, and Mydayis
    • Why dextroamphetamine-only options (Vyvanse) work better for some patients than mixed amphetamine salts (Adderall)
    • The 25-30% of adult patients who do best on a pure dextroamphetamine
    • Why "all good, no bad" is the optimization standard, not "good enough"
    • The diagnostic value of medication response: if any properly trialed medication works, the diagnosis is confirmed and other options remain available
    • Why FDA-recommended dosing limits are appropriate guardrails, not arbitrary restrictions

    This episode references the Top 10 ADHD Stimulants video on the Focus Path YouTube channel: https://youtu.be/xJQLSCGY9Vc

    This is the third episode in the sequence covering the optimization process from the book The Process: An Adult's Guide to ADHD Medication, available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T

    Find the YouTube channel Focus Path | PMHNP-BC for the full clinical education catalog.

    For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.

    Show More Show Less
    13 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet